Connection
Christine Fisher to Trastuzumab
This is a "connection" page, showing publications Christine Fisher has written about Trastuzumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.046 |
|
|
|
-
Stoen E, Kagihara J, Shagisultanova E, Fisher CM, Nicklawsky A, Kabos P, Borges VF, Diamond JR. Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval. Breast Cancer Res Treat. 2021 Jun; 187(3):883-891.
Score: 0.046